The Vanguard Group 13D and 13G filings for Sorrento Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Sorrento Therapeutics, Inc. SRNE |
The Vanguard Group | 29,535,954 6.260% |
13,843,224 (+88.21%) |
Filing |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Sorrento Therapeutics, Inc. SRNE |
The Vanguard Group | 15,692,730 5.120% |
15,692,730 (New Position) |
Filing |